Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (74608)	1/18/2024 12:09:40 PM
From: Grommit	1 Recommendation Recommended By Lance Bredvold Read Replies (2) \| Respond to of 78753

Med Insurers. I looked but did not buy. Yes, there may be a moat, but they are now all in the same boat. (mixed metaphors.) I usually do not post news since you can read that yourself. Mkt overreaction? But as I said >> Not sure how these fit into my criteria of easy to understand and predictable. Evidently, too complicated, competition, lack of control over costs, and maybe pricing... ???? Shares of Humana fell nearly 12% and its managed-care competitors also dropped Thursday after the Medicare-focused insurer warned... Humana also said it added fewer new members than it had projected during the fall enrollment period for its core Medicare business. The company's news, following UnitedHealth Group's recent disclosure of higher Q4 medical costs, adds to concerns about health insurers' results, particularly in the Medicare business. UnitedHealth, CVS Health, Elevance and Centene were also down.

To: Spekulatius who wrote (74608)	10/17/2024 12:56:28 PM
From: Paul Senior	1 Recommendation Recommended By Lance Bredvold Read Replies (2) \| Respond to of 78753

Not a good day for medical insurers. HUM continues to fall as ELV and CNC tumble. WSJ: "Like other insurers, Elevance is saying that the rates it is paid under the government program for low-income Americans fall short of what it needs, due to the medical costs of Medicaid enrollees. The mismatch is tied to a wave of enrollees being dropped from Medicaid after the government reintroduced eligibility checks, which it had suspended during the public-emergency period implemented amid the pandemic. Elevance executives said the issues are “time bound,” and it will negotiate higher Medicaid rates, but the process will take time. The company said that it expects the gap between its Medicaid payments and costs to narrow in 2025, and that it was confident in its Medicaid and Medicare businesses over the long term." I continue to hold for now. Drop in ELV and destruction of my gains here is totally on me. Could have foreseen it happening to to ELE given HUM's reports and its subsequent earilier stock drop. A general problem with having so diverse a portfolio - not able to focus well on individual stocks and implications for them. Also my being old and slow doesn't help.